Friday, October 30, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 27, 2026

Top Research Reports for Broadcom, Oracle & Mastercard

View original at finance.yahoo.com
“Gencor Industries' shares have declined -13.6% over the past year against the Zacks Manufacturing - Thermal Products industry's decline of -39%. This microcap company with a market capitalization of $199.35 million has seen a sharp backlog decline, which reduces near-term visibility, while rising obsolete inventory reserves, lower R&D spend and reliance on volatile investment income te”
Verbatim excerpt from the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Broadcom expects first-quarter fiscal 2026 AI revenues to double to $8.2 billion

    80% confidence
  • ADM Nutrition revenues rose 4.6% while segment operating profit grew 24% on robust Flavors portfolio in Q3

    80% confidence
  • Interactive Brokers' efforts to expand product suite and develop proprietary software will likely aid top line and help garner market share

    80% confidence
  • Competition from hyperscalers remains intense for Oracle, potentially pressuring margins

    80% confidence
  • Oracle's ongoing transition from license revenue to subscription models creates near-term earnings volatility

    80% confidence
  • Mastercard rebates and incentives increased 15% YoY in the first nine months of 2025

    80% confidence
  • Broadcom is experiencing strong momentum fueled by growth in AI semiconductors and continued success with its VMware integration

    80% confidence
  • Oracle's cloud infrastructure business demonstrates accelerating revenue growth supported by strategic partnerships and competitive pricing

    80% confidence
  • Geospace Technologies Smart Water remains the core growth driver, posting 10.4% fiscal 2025 revenue growth on rising Hydroconn and Aquana adoption

    80% confidence
  • PulteGroup is hurting from weak consumer confidence and ongoing affordability challenges and elevated sales incentives and cost pressures are denting margins

    80% confidence
  • Gencor Industries ended fiscal 2025 with $136.3 million in cash and marketable securities and no debt

    80% confidence
  • Doximity leverages unmatched physician reach and AI-driven tools to solidify its role as healthcare's essential B2B engagement platform with strong profitability

    80% confidence
  • RLI Corp's exposure to cat losses has been weighing on underwriting profitability and higher expenses have been inducing margin contraction

    80% confidence
  • Microchip Technology's expanding product portfolio, solid demand for Gen 4 and Gen 5 data center products and AI investments are key catalysts

    80% confidence
  • Immunovant's steady progress across autoimmune programs is promising, but its narrow pipeline and fierce competition in the immunology space could hinder long-term growth

    80% confidence
  • Broadcom's gross margin in the fiscal first quarter is expected to contract sequentially and high debt level is a headwind

    80% confidence
  • Halliburton's offshore project portfolio strengthens its market position but challenges with the SAP migration project may affect near-term earnings potential

    80% confidence
  • Oracle's Fiscal 2026 guidance indicates continued cloud acceleration but execution risks around data center capacity expansion warrant monitoring

    80% confidence
  • Devon Energy results are likely to be pressured by competition to secure drilling rights and acquire assets, and new regulations could raise costs

    80% confidence
  • Mastercard expects adjusted operating expenses to witness high-end of mid-teens YoY growth in 2025

    80% confidence
  • Gencor Industries fiscal 2025 gross margin remained stable at 27.5% and operating income rose 2.4%

    80% confidence
  • Mastercard net revenues rose 16% YoY in the first nine months of 2025

    80% confidence
  • Mastercard paid dividends of $2.1 billion in the first nine months of 2025

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com